Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease

• by Zhengtai Sun, Yuting Liu, Lijuan Que

• May 28, 2026

Driving Progress in Dry Eye Care

WCO and Alcon renew global dry eEye education partnership

• February 5, 2026

• 3 min

Computational pharmacovigilance of Lifitegrast in dry eye disease using machine learning and network toxicology

• by Lin Li, Shixiang Jing, Xuhua Zhao, Xinyue Zhu, Chunyu Liang, Leite Shi, Pengyi Zhou, Kunpeng Xie, Bo Jin, Haiyan Zhu, Yuying Wang, Xuemin Jin, Liping Du, Peizeng Yang

• January 9, 2026

Investigation of the Relationship Between Ocular Surface Metrics and Corneal Higher-Order Aberrations in Patients with Dry Eye Disease: A Cross-Sectional Analysis

• by Yanmei Fang, Hezheng Zhou, Dan Xia, Kuiliang Yang, Han Zhang, Xiaoxi Deng, Yan Pan, Xiaohong Xiang, Tingting Fan, Xiaoli Jin, Wanju Yang

• January 27, 2026